Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 Global Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 Global Sexually Transmitted Diseases (STD) Testing Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. Global Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 Global Chlamydia Market by Region
4.2 Global Herpes simplex virus Market by Region
4.3 Global Gonorrhea Market by Region
4.4 Global Syphilis Market by Region
4.5 Global Human papillomavirus (HPV) Market by Region
4.6 Global Other Disease Market by Region
Chapter 5. Global Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 Global Laboratory Testing Market by Region
5.2 Global Point of care (POC) Testing Market by Region
Chapter 6. Global Sexually Transmitted Diseases (STD) Testing Market by Region
6.1 North America Sexually Transmitted Diseases (STD) Testing Market
6.1.1 North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.1.1 North America Chlamydia Market by Country
6.1.1.2 North America Herpes simplex virus Market by Country
6.1.1.3 North America Gonorrhea Market by Country
6.1.1.4 North America Syphilis Market by Country
6.1.1.5 North America Human papillomavirus (HPV) Market by Country
6.1.1.6 North America Other Disease Market by Country
6.1.2 North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.2.1 North America Laboratory Testing Market by Country
6.1.2.2 North America Point of care (POC) Testing Market by Country
6.1.3 North America Sexually Transmitted Diseases (STD) Testing Market by Country
6.1.3.1 US Sexually Transmitted Diseases (STD) Testing Market
6.1.3.1.1 US Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.1.2 US Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.2 Canada Sexually Transmitted Diseases (STD) Testing Market
6.1.3.2.1 Canada Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.2.2 Canada Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.3 Mexico Sexually Transmitted Diseases (STD) Testing Market
6.1.3.3.1 Mexico Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.3.2 Mexico Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.1.3.4 Rest of North America Sexually Transmitted Diseases (STD) Testing Market
6.1.3.4.1 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.3.4.2 Rest of North America Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 Europe Sexually Transmitted Diseases (STD) Testing Market
6.2.1 Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.1.1 Europe Chlamydia Market by Country
6.2.1.2 Europe Herpes simplex virus Market by Country
6.2.1.3 Europe Gonorrhea Market by Country
6.2.1.4 Europe Syphilis Market by Country
6.2.1.5 Europe Human papillomavirus (HPV) Market by Country
6.2.1.6 Europe Other Disease Market by Country
6.2.2 Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.2.1 Europe Laboratory Testing Market by Country
6.2.2.2 Europe Point of care (POC) Testing Market by Country
6.2.3 Europe Sexually Transmitted Diseases (STD) Testing Market by Country
6.2.3.1 Germany Sexually Transmitted Diseases (STD) Testing Market
6.2.3.1.1 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.1.2 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.2 UK Sexually Transmitted Diseases (STD) Testing Market
6.2.3.2.1 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.2.2 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.3 France Sexually Transmitted Diseases (STD) Testing Market
6.2.3.3.1 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.3.2 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.4 Russia Sexually Transmitted Diseases (STD) Testing Market
6.2.3.4.1 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.4.2 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.5 Spain Sexually Transmitted Diseases (STD) Testing Market
6.2.3.5.1 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.5.2 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.6 Italy Sexually Transmitted Diseases (STD) Testing Market
6.2.3.6.1 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.6.2 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2.3.7 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
6.2.3.7.1 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.3.7.2 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
6.3.1 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.1.1 Asia Pacific Chlamydia Market by Country
6.3.1.2 Asia Pacific Herpes simplex virus Market by Country
6.3.1.3 Asia Pacific Gonorrhea Market by Country
6.3.1.4 Asia Pacific Syphilis Market by Country
6.3.1.5 Asia Pacific Human papillomavirus (HPV) Market by Country
6.3.1.6 Asia Pacific Other Disease Market by Country
6.3.2 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.2.1 Asia Pacific Laboratory Testing Market by Country
6.3.2.2 Asia Pacific Point of care (POC) Testing Market by Country
6.3.3 Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Country
6.3.3.1 China Sexually Transmitted Diseases (STD) Testing Market
6.3.3.1.1 China Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.1.2 China Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.2 Japan Sexually Transmitted Diseases (STD) Testing Market
6.3.3.2.1 Japan Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.2.2 Japan Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.3 India Sexually Transmitted Diseases (STD) Testing Market
6.3.3.3.1 India Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.3.2 India Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.4 South Korea Sexually Transmitted Diseases (STD) Testing Market
6.3.3.4.1 South Korea Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.4.2 South Korea Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.5 Singapore Sexually Transmitted Diseases (STD) Testing Market
6.3.3.5.1 Singapore Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.5.2 Singapore Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.6 Malaysia Sexually Transmitted Diseases (STD) Testing Market
6.3.3.6.1 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.6.2 Malaysia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3.3.7 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market
6.3.3.7.1 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.3.7.2 Rest of Asia Pacific Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.4.1 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.1.1 LAMEA Chlamydia Market by Country
6.4.1.2 LAMEA Herpes simplex virus Market by Country
6.4.1.3 LAMEA Gonorrhea Market by Country
6.4.1.4 LAMEA Syphilis Market by Country
6.4.1.5 LAMEA Human papillomavirus (HPV) Market by Country
6.4.1.6 LAMEA Other Disease Market by Country
6.4.2 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.2.1 LAMEA Laboratory Testing Market by Country
6.4.2.2 LAMEA Point of care (POC) Testing Market by Country
6.4.3 LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country
6.4.3.1 Brazil Sexually Transmitted Diseases (STD) Testing Market
6.4.3.1.1 Brazil Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.1.2 Brazil Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.2 Argentina Sexually Transmitted Diseases (STD) Testing Market
6.4.3.2.1 Argentina Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.2.2 Argentina Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.3 UAE Sexually Transmitted Diseases (STD) Testing Market
6.4.3.3.1 UAE Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.3.2 UAE Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
6.4.3.4.1 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.4.2 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.5 South Africa Sexually Transmitted Diseases (STD) Testing Market
6.4.3.5.1 South Africa Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.5.2 South Africa Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.6 Nigeria Sexually Transmitted Diseases (STD) Testing Market
6.4.3.6.1 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.6.2 Nigeria Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4.3.7 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market
6.4.3.7.1 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.3.7.2 Rest of LAMEA Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
Unique Offerings 